New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For ACUR From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 2, 2015
16:32 EDTACURAcura Pharma reports Q4 EPS (6c), consensus (9c)
For the twelve months ended December 31, Acura recorded $0.5M in license fee revenue and $0.2M in net product sales from NEXAFED as compared with $0.1M in net product sales from NEXAFED in the same period in 2013. In the fourth quarter of 2014, the Company shipped $0.2M of NEXAFED but has recognized only a portion of those shipments to customers until the right of return no longer exists or adequate history and information becomes available to estimate product returns. At December 31, the company has deferred the recognition of $0.4M in NEXAFED revenue and $0.2M in related cost of sales.
February 27, 2015
09:58 EDTACUROn The Fly: Analyst Upgrade Summary
Subscribe for More Information
06:27 EDTACURAcura Pharma upgraded to Buy from Hold at MLV & Co.
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use